- Coordinates
- PDB Format
- Method
- SOLUTION NMR
- Oligo State
- hetero-2-2-mer
- Ligands
- 64 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 16 x 17F: O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine(Non-covalent)(Non-functional Binders)
17F.15: 6 residues within 4Å:- Chain A: F.188
- Chain D: T.183
- Ligands: PCW.3, PCW.4, PCW.14, 17F.63
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:F.188, D:T.183
17F.16: 3 residues within 4Å:- Chain A: L.170
- Ligands: PCW.57, PCW.58
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.170
17F.22: 6 residues within 4Å:- Ligands: PCW.10, PCW.28, PCW.44, 17F.54, 17F.83, 17F.84
No protein-ligand interaction detected (PLIP)17F.50: 6 residues within 4Å:- Ligands: PCW.23, PCW.24, PCW.29, PCW.30, PCW.31, 17F.51
No protein-ligand interaction detected (PLIP)17F.51: 5 residues within 4Å:- Chain B: W.67, M.71
- Ligands: PCW.24, PCW.30, 17F.50
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.67
17F.52: 5 residues within 4Å:- Chain B: Y.195, T.196, N.200
- Ligands: PCW.21, PCW.27
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.195
17F.53: 8 residues within 4Å:- Ligands: PCW.8, PCW.13, PCW.32, PCW.41, PCW.44, PCW.49, PCW.75, PCW.82
No protein-ligand interaction detected (PLIP)17F.54: 8 residues within 4Å:- Ligands: PCW.2, 17F.22, PCW.28, PCW.31, PCW.38, PCW.43, PCW.44, PCW.73
No protein-ligand interaction detected (PLIP)17F.63: 9 residues within 4Å:- Chain D: K.182, T.183, K.184
- Ligands: PCW.14, 17F.15, PCW.36, PCW.46, PCW.57, PCW.76
No protein-ligand interaction detected (PLIP)17F.64: 11 residues within 4Å:- Chain C: K.178, K.179, K.180, S.181, K.182
- Ligands: PCW.9, PCW.57, PCW.58, PCW.60, PCW.61, PCW.70
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:K.180, C:S.181, C:S.181
- Salt bridges: C:K.179, C:K.179
17F.65: 6 residues within 4Å:- Ligands: PCW.3, PCW.5, PCW.6, PCW.11, PCW.59, PCW.69
No protein-ligand interaction detected (PLIP)17F.78: 7 residues within 4Å:- Ligands: PCW.26, PCW.68, PCW.69, PCW.71, PCW.72, PCW.73, PCW.77
No protein-ligand interaction detected (PLIP)17F.79: 7 residues within 4Å:- Ligands: PCW.24, PCW.31, PCW.38, PCW.60, PCW.70, PCW.71, PCW.74
No protein-ligand interaction detected (PLIP)17F.80: 9 residues within 4Å:- Chain C: K.178
- Chain D: K.176, K.178
- Ligands: PCW.19, PCW.26, PCW.45, PCW.70, PCW.76, PCW.77
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Salt bridges: D:K.176, D:K.178, C:K.178
17F.83: 5 residues within 4Å:- Ligands: 17F.22, PCW.26, PCW.28, PCW.82, 17F.84
No protein-ligand interaction detected (PLIP)17F.84: 8 residues within 4Å:- Ligands: 17F.22, PCW.25, PCW.26, PCW.28, PCW.69, PCW.81, PCW.82, 17F.83
No protein-ligand interaction detected (PLIP)- 2 x GSP: 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE(Non-covalent)
GSP.55: 23 residues within 4Å:- Chain C: A.11, D.12, G.13, V.14, G.15, K.16, S.17, A.18, F.28, V.29, D.30, Y.32, D.33, P.34, T.35, D.57, N.116, K.117, D.119, L.120, A.146, K.147
- Ligands: MG.56
19 PLIP interactions:19 interactions with chain C- Hydrogen bonds: C:G.13, C:V.14, C:G.15, C:K.16, C:S.17, C:A.18, C:Y.32, C:T.35, C:N.116, C:K.117, C:K.117, C:D.119, C:D.119, C:A.146, C:K.147, C:K.147
- pi-Stacking: C:F.28, C:F.28
- pi-Cation interactions: C:K.117
GSP.66: 25 residues within 4Å:- Chain D: A.11, G.13, V.14, G.15, K.16, S.17, A.18, F.28, V.29, D.30, Y.32, D.33, P.34, T.35, D.57, T.58, G.60, N.116, K.117, D.119, L.120, S.145, A.146, K.147
- Ligands: MG.67
22 PLIP interactions:22 interactions with chain D- Hydrogen bonds: D:G.13, D:V.14, D:G.15, D:K.16, D:K.16, D:S.17, D:A.18, D:D.30, D:D.33, D:D.33, D:T.35, D:G.60, D:N.116, D:K.117, D:K.117, D:S.145, D:A.146, D:K.147
- Salt bridges: D:K.16, D:D.119
- pi-Stacking: D:F.28, D:F.28
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.56: 4 residues within 4Å:- Chain C: S.17, T.35, D.57
- Ligands: GSP.55
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:S.17, C:T.35, C:D.57
MG.67: 4 residues within 4Å:- Chain D: S.17, T.35, D.57
- Ligands: GSP.66
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:S.17, D:T.35, D:D.57
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, K.Y. et al., Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement. Angew.Chem.Int.Ed.Engl. (2020)
- Release Date
- 2020-04-15
- Peptides
- Apolipoprotein A-I: AB
GTPase KRas: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C
- Coordinates
- PDB Format
- Method
- SOLUTION NMR
- Oligo State
- hetero-2-2-mer
- Ligands
- 64 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 16 x 17F: O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine(Non-covalent)(Non-functional Binders)
- 2 x GSP: 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, K.Y. et al., Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement. Angew.Chem.Int.Ed.Engl. (2020)
- Release Date
- 2020-04-15
- Peptides
- Apolipoprotein A-I: AB
GTPase KRas: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C